You are here:-Resources
This section is under development. Below you find examples of resources that will be provided in this section. If you have any suggestions or requests for resources, please let us know. Click here to get in touch with us.

Courses and conferences

Link Description
The 12th Berlin Conference on Life Sciences – Novel Antimicrobials and AMR Diagnostics 2019

14 – 15  March 2019 – Berlin, Germany

Image result for superbugs and superdrugs Superbugs & Superdrugs 2019

18 – 19 March 2019 – London, United Kingdom

BSAC Spring Conference 2019

21 – 22 March 2019 – Birmingham, United Kingdom

World Anti-Microbial Resistance Congress Europe

26 – 27 March 2019 – Berlin, Germany

The 29th European Congress of Clinical Microbiology and Infectious Diseases

13 – 16 April 2019 – Amsterdam, Netherlands

ESDPPP2019 The 17th Congress of the European Society for Developmental Perinatal and Paediatric Pharmacology

28 – 30 May 2019 – Basel, Switzerland

Image result for asm microbe 2019 ASM Microbe 2019

20 – 24 June 2019 – San Francisco, CA

WVA 2018 STI & HIV 2019 World Congress

14 – 17 July 2019 – Vancouver, Canada

ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

3 – 6 September 2019 – Boston, Massachusetts

IUSTI Europe IUSTI Europe Congress 2019

5 – 7 September 2019 – Tallinn, Estonia

World Health Summit 2019

27 – 29 October 2019 – Berlin, Germany

The 11th World Congress of the World Society for Pediatric Infectious Diseases

5 – 8 November 2019 – Manila, Philippines

World Anti-Microbial Resistance Congress 2019

7 – 8 November 2019 – Washington, D.C.

Open-access resources

Link Description
Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics (World Health Organization, 2017)
Antibacterial Agents in Clinical Development – An analysis of the antibacterial clinical development pipeline including tuberculosis (World Health Organization, 2017)
AntibioticDB is a free, open-access database of antibacterial compounds, including discontinued agents, drugs under pre-clinical development and those in clinical trials.
A frequently updated data visualization of antibiotics currently in global clinical development (The Pew Charitable Trusts, Antibiotic Resistance Project, last updated September 2018)

R&D funding mechanisms

Link Description
CARB-X is investing $455 million in 2016-2021 to support the development of antibiotics and other therapies, vaccines, rapid diagnostics and devices to address the rising global threat of drug-resistant bacteria.
The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is funding 65 M Euros of basic and exploratory research on new antibiotics, stewardship of existing antibiotics, and studies and control of the spread of antibiotic resistance between humans, animals, and the environment in a One Health perspective.

Organizations and projects

Link Description
European Society of Clinical Microbiology and Infectious Diseases (ESCMID)